VGM & ASSOCIATESHealthcare MSO
Full Menu Search

Corporate Transparency Act – Reporting Requirements for Certain Businesses in 2024

Published in Government Relations on January 23, 2024

Certain U.S. business types, including corporations and LLCs, are now required to submit reports regarding their ownership. Failure to submit these reports can result in both financial penalties and/or prison time. While this new reporting requirement is not specific to the DMEPOS industry, we know that several of our members’ companies will be subject to these new reporting requirements due to size and corporate structure, and we want to make sure those companies are aware of these new requirements and can take the necessary steps to avoid the monetary and criminal penalties associated with non-compliance.

The Corporate Transparency Act, enacted in 2021, held provisions that require certain business types to begin submitting reports in 2024 regarding the people who own, or directly/indirectly, control their business. These reports are called BOI (Beneficial Ownership Information) reports and will be submitted to an entity called FinCEN (Financial Crimes Enforcement Network). The reporting requirements begin in 2024 for some companies and 2025 for others. Failure to submit these reports if you are required to do so, or submitting false information within the reports, can result in 1) fines of up to $10,000 or a fine of $500 per day for each day of non-compliance, and 2) criminal penalties of up to two years in prison.

WHO IS REQUIRED TO REPORT?

U.S.-based corporations, limited liability companies (LLCs), and any other entities created by the filing of a document with a secretary of state or any similar office in the United States are required to submit BOI reports to FinCEN. There are, however, currently 23 specific exceptions regarding who has to submit reports, and those exceptions are outlined in section 1.2 of FinCEN’s published compliance guide found here. For example, one of the exemptions is for companies that have 20 U.S.-based employees and gross receipts totaling more than $5 million.

There will be no cost to businesses to submit these reports. They can be submitted electronically on FinCEN’s website.

WHEN ARE REPORTS REQUIRED TO BE SUBMITTED?

If your business is subject to the reporting requirements, the date your first report is due depends on when your company was created and registered to conduct business:

  • If your business was created or registered before Jan. 1, 2024, the deadline to submit your first report is Jan. 1, 2025.
  • If your business was created during calendar year 2024, you will have 90 days from whichever of the two dates comes first:
    • The date your company receives actual notice that its creation/registration is effective.
    • The date on which the Secretary of State, or similar office, first provides public notice of when the company was created or registered.
  • If your business was created after Jan. 1, 2025, you will have 30 days from whichever of the two dates comes first:
    • The date your company receives actual notice that its creation/registration is effective.
    • The date on which the Secretary of State, or similar office, first provides public notice of when the company was created or registered.

Below are some helpful resources to help you better understand these new requirements and whether your business is subject to them.

While this is not a DME industry-specific requirement, we know it will impact some of our members, and we want to make sure anyone who is subject to these requirements is aware of them and compliant with them. If you have any questions, please reach out to the VGM Government Payer Relations Experts at 800-642-6065.

TAGS

  1. vgm government

Get Connected

Stay up-to-date on the latest resources and news provided by VGM & Associates.

Sign Up for Email

From Our Experts

Join HME Industry Letter on CB Program to CMS Administrator Oz thumbnail Join HME Industry Letter on CB Program to CMS Administrator Oz HME suppliers, manufacturers, and distributors are invited to add their company's name to a letter to CMS Administrator Dr. Mehmet Oz regarding the Administration's DMEPOS/Home Health Proposed Rule that includes provisions for a new competitive bidding round. The letter specifically asks CMS to withdraw or delay the DMEPOS provisions in the Proposed Rule and re-engage with industry, patient, and clinical stakeholders to design an evidence-based, fraud-resistant, America-First framework. Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program thumbnail Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program Now is the time to raise our voices. With the formal announcement of the Competitive Bidding (CB) Program expected as early as the end of this month, we must act swiftly and decisively. Below are two key opportunities to engage with your U.S. Representative and encourage their support for a Congressional letter urging Centers for Medicare & Medicaid Services (CMS) to pause and reassess the CB Program. Legislative Momentum in the HME Industry: Key Updates & Action Items thumbnail Legislative Momentum in the HME Industry: Key Updates & Action Items The past few months have seen a surge of legislative activity in the home medical equipment sector, with several key developments shaping policy and advocacy efforts across the industry. From new bills introduced in Congress to formal comment submissions and stakeholder mobilization, these events reflect growing momentum around critical issues affecting providers and patients alike. This article offers a comprehensive recap of recent actions and outlines important next steps for those... VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports thumbnail VGM Submits Comments Regarding the Section 232 National Security Investigation On Medical Imports VGM has submitted formal comments to the U.S. Department of Commerce in response to its Section 232 National Security Investigation into the importation of personal protective equipment (PPE), medical consumables, and medical equipment and devices. Senate Backs DME Relief Act with Bipartisan Support thumbnail Senate Backs DME Relief Act with Bipartisan Support In a significant development for the durable medical equipment (DME) industry and Medicare beneficiaries, the U.S. Senate has introduced S.2951, the companion legislation to H.R. 2005, known as the DMEPOS Relief Act of 2025. The Senate bill is being led by Senator James Lankford (R-OK) and has gained bipartisan support with Senator Maggie Hassan (D-NH) joining as a co-sponsor. Gov't Shutdown: What It Means for Providers thumbnail Gov't Shutdown: What It Means for Providers As expected, Democrats and Republican members of the Senate was unable to agree on terms in passing a continuing resolution (CR) ahead of the October 1st deadline, resulting in a government shutdown. But how did we get here? Oppose DMEPOS Bidding Expansion – Take Action Now thumbnail Oppose DMEPOS Bidding Expansion – Take Action Now A critical Congressional Sign-On Letter is now circulating in the House of Representatives, led by Reps. Neal Dunn (R-FL) and Greg Murphy (R-NC). This bipartisan letter calls on CMS to stop the proposed expansion of the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) Competitive Bidding Program to include ostomy and urological supplies. Gov't Shutdown & Telehealth Flexibility Expiration thumbnail Gov't Shutdown & Telehealth Flexibility Expiration September 30 represents an important date for HME providers for two reasons: 1) The potential of a government shutdown and how that affects HHS and CMS, and 2) the expiration of Telehealth Flexibilities unless a Continuing Resolution (CR) is agreed upon in time.

Give your business an advantage over the competition.

Become a Member